Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07EPU
|
||||
Former ID |
DNC006950
|
||||
Drug Name |
ADS-103254
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C23H26F3N5O2
|
||||
Canonical SMILES |
CC1=NC(=NC2=C1C=C(C=C2)NC(=O)COC3=CC=C(C=C3)C(F)(F)F)N(<br />C)CCN(C)C
|
||||
InChI |
1S/C23H26F3N5O2/c1-15-19-13-17(7-10-20(19)29-22(27-15)31(4)12-11-30(2)3)28-21(32)14-33-18-8-5-16(6-9-18)23(24,25)26/h5-10,13H,11-12,14H2,1-4H3,(H,28,32)
|
||||
InChIKey |
ZALRLWFCZSVMRA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Melanin-concentrating hormone receptor 1 | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Reactome | Peptide ligand-binding receptors | ||||
G alpha (q) signalling events | |||||
G alpha (i) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2007 Mar 1;17(5):1403-7. Epub 2006 Dec 2.Quinazoline and benzimidazole MCH-1R antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.